
SynBioBeta 2026 Speaker
Mario Fuenzalida
Lipock
CEO
Mario Fuenzalida is a second-time founder and the CEO of Lipock, with deep expertise in global Go-To-Market (G2M) strategies and scaling deeptech ventures. Having previously led international teams and raised venture capital for science-based models (The Earth Says), Mario specializes in bridging the gap between advanced research and mass-market industrial adoption.At Lipock, Mario drives the commercial strategy to replace synthetic additives with edible nanotechnology. By leveraging a proprietary nanolipid platform that reduces natural bioactive dosages by up to 45 times, he enables global CPG and cosmetic manufacturers to achieve cost-parity with synthetic ingredients. His leadership focuses on providing a scalable solution to the "2027 Regulatory Cliff," allowing brands to transition to clean-label products without sacrificing profit margins. A Hello Tomorrow 2026 Pioneer backed by GridX, Mario is redefining how green chemistry reaches global industrial scales.



Reagan
Jarvis
Anocca AB
CEO, Co-founder

Alex
Rives
CZI Biohub
Head of Science

Karenโฏ
Akinsanya
Schrodinger
President, R&D โ Therapeutics

Christopher
Arendt
Takeda
CSO, Head of Research

Stef
van Grieken
Cradle
CEO

Michael
Koeris
DARPA
Director, BTO

Jennifer
Dionne
Pumpkinseed
CEO

Daniyal
Hussain
GSK
Exec. Dir., Tech BD

Cynthia
Hong
Novartis
Dir., Search & Evaluation
SynBioBeta 2027 May 3-6, San Jose, California


